a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PSVDX | 19.63 | 0.36 | +1.87% |
PGIM Quant Solutions Small-Cap Val R2 | |||
NPSGX | 15.91 | 0.01 | +0.06% |
Nicholas Partners Small Cap Gr Instl | |||
CCMMX | 9.32 | N/A | N/A |
Conestoga Mid Cap Investors | |||
AFDIX | 52.82 | -0.36 | -0.68% |
American Century Sustainable Equity Inv | |||
BMCRX | 24.52 | -0.18 | -0.73% |
BlackRock Advantage Large Cap Gr R |
A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with CDTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then CDTX could also see price increases.
Ticker / NAME | Correlation To ADVM | 1D Price Change % | ||
---|---|---|---|---|
ADVM | 100% | +2.80% | ||
CDTX - ADVM | 38% Loosely correlated | +2.62% | ||
VNDA - ADVM | 33% Poorly correlated | -0.32% | ||
IMNM - ADVM | 32% Poorly correlated | +5.74% | ||
KPTI - ADVM | 31% Poorly correlated | +1.43% | ||
CYTK - ADVM | 27% Poorly correlated | +2.95% | ||
More |